Prospective evaluation of c-reactive protein as a diagnostic biomarker with correlation to blood culture and antibiotic susceptibility patterns in neonatal sepsis: A cross-sectional study.
DOI:
https://doi.org/10.51168/kd82c583Cuvinte cheie:
Neonatal sepsis, C-reactive protein, Blood culture, Antibiogram, Antimicrobial resistance, Neonatal Intensive Care UnitRezumat
Background
Neonatal sepsis remains a major cause of neonatal morbidity and mortality. Its clinical features are often nonspecific, while blood culture, although definitive, has delayed turnaround and variable yield. C-reactive protein (CRP) is a simple acute-phase marker that supports early decision-making when correlated with microbiological findings.
Objectives
To evaluate the diagnostic utility of CRP in suspected neonatal sepsis and correlate CRP status with blood culture positivity and antimicrobial susceptibility patterns.
Methods
This prospective cross-sectional study was conducted from January 2024 to December 2024 in the Neonatal Intensive Care Unit of Government General Hospital, Suryapet, a tertiary care teaching hospital attached to Government Medical College, Suryapet, Telangana, India. A total of 302 neonates with suspected sepsis were enrolled. Blood samples were collected aseptically before antibiotic administration for CRP estimation and culture. Quantitative CRP was measured using the RHELAX-CRP latex agglutination method, with >6 mg/L considered elevated. Blood cultures and antibiotic susceptibility testing were performed using standard microbiological methods and CLSI guidance.
Results
Among 302 neonates, 178 (58.9%) were males, 186 (61.6%) had low birth weight and 164 (54.3%) were preterm. Blood culture was positive in 70 neonates (23.2%). Gram-negative bacteria predominated, comprising 48 isolates (68.6%), with Klebsiella pneumoniae as the commonest isolate. Elevated CRP was observed in 50 culture-positive neonates. CRP showed 71.4% sensitivity, 92.2% specificity, 73.5% positive predictive value and 91.5% negative predictive value. Elevated CRP was significantly associated with culture positivity (p<0.001). Gram-negative isolates showed high resistance to cefotaxime and ceftriaxone, with better sensitivity to imipenem and piperacillin-tazobactam.
Conclusion
CRP is a useful adjunctive marker for neonatal sepsis, especially due to its high specificity and strong culture correlation.
Recommendations
CRP testing should complement blood culture to guide early antibiotics and strengthen NICU antimicrobial stewardship
Referințe
1. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223-230. https://doi.org/10.1016/S2213-2600(18)30063-8
2. Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770-1780.
https://doi.org/10.1016/S0140-6736(17)31002-4
3. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60(2):367-389. https://doi.org/10.1016/j.pcl.2012.12.003
4. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21-47.
https://doi.org/10.1128/CMR.00031-13
5. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257-F263.
https://doi.org/10.1136/archdischild-2014-306213
6. Celik IH, Hanna M, Canpolat FE, Pammi M. Diagnosis of neonatal sepsis: the past, present and future. Pediatr Res. 2022;91(2):337-350. https://doi.org/10.1038/s41390-021-01696-z
7. Eichberger J, Resch E, Resch B. Diagnosis of neonatal sepsis: the role of inflammatory markers. Front Pediatr. 2022;10:840288.
https://doi.org/10.3389/fped.2022.840288
8. Cantey JB, Baird SD. Biomarkers for the diagnosis of neonatal sepsis. Clin Perinatol. 2021;48(2):215-227.
https://doi.org/10.1016/j.clp.2021.03.012
9. Brown JVE, Meader N, Wright K, Cleminson J, McGuire W. Assessment of C-reactive protein diagnostic test accuracy for late-onset infection in newborn infants: a systematic review and meta-analysis. JAMA Pediatr. 2020;174(3):260-268.
https://doi.org/10.1001/jamapediatrics.2019.5669
10. Brown JVE, Meader N, Cleminson J, McGuire W. C-reactive protein for diagnosing late-onset infection in newborn infants. Cochrane Database Syst Rev. 2019;1(1):CD012126. https://doi.org/10.1002/14651858.CD012126.pub2
11. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4):E41. https://doi.org/10.1542/peds.102.4.e41
12. Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in neonatal sepsis. Acta Paediatr. 2021;110(3):705-710. https://doi.org/10.1111/apa.15562
13. Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health. 2016;4(10):e752-e760. https://doi.org/10.1016/S2214-109X(16)30148-6
14. Chaurasia S, Sivanandan S, Agarwal R, Ellis S, Sharland M, Sankar MJ. Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 2019;364:k5314. https://doi.org/10.1136/bmj.k5314
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2024. 16. Folgori L, Bielicki J, Heath PT, Sharland M. Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment. Curr Opin Infect Dis. 2017;30(3):281-288. https://doi.org/10.1097/QCO.0000000000000371
17. Sands K, Carvalho MJ, Portal E, Thomson K, Dyer C, Akpulu C, et al. Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat Microbiol. 2021;6(4):512-523.
https://doi.org/10.1038/s41564-021-00870-7
18. Klingenberg C, Kornelisse RF, Buonocore G, Maier RF, Stocker M. Culture-negative early-onset neonatal sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship. Front Pediatr. 2018;6:285.
https://doi.org/10.3389/fped.2018.00285
19. Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics. 2017;140(4):e20170044.
https://doi.org/10.1542/peds.2017-0044
20. Esaiassen E, Fjalstad JW, Juvet LK, van den Anker JN, Klingenberg C. Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis. J Antimicrob Chemother. 2021;76(8):1858-1870.
Descărcări
Publicat
Număr
Secțiune
Licență
Copyright (c) 2026 Dr. Sri Dharani Munagala, Dr. Aditi Tomer Thakur, Dr. S Ruth Ramya, Dr. Taruni, Dr. R Kondal Rao, Dr. Nagasaikaran Sade

TAceastă lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.














